GlobeStar Therapeutics Corporation (OTCPK: GSTC)
Health Care · Biotechnology · US
$—
— today · — 1Y
GlobeStar Therapeutics Corporation (OTCPK: GSTC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.24K and employs 0 people.
trading between 0.00 and 0.00.
Tweenvest scores GlobeStar Therapeutics Corporation across four factors: quality 11/100, value 37/100. Its strongest factor is value.
GSTC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.24K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 1.12
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.24B
- Employees
- 0
- Next earnings
- —
About GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
- ISIN
- US37960P1049
- Listed since
- Sep 26, 2011
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| IMAC Holdings, Inc.OTCPK: BACK | $2.27K | $0.00 | +20.00% |
| Evelo Biosciences, Inc.OTCPK: EVLO | $1.90K | $0.00 | — |
| RegeneRx Biopharmaceuticals, Inc.OTCPK: RGRX | $1.66K | $— | — |
| Evolutionary Genomics, Inc.OTCPK: FNAM | $1.33K | $— | — |
| Adhera Therapeutics, Inc.OTCPK: ATRX | $1.16K | $— | — |
| EV Biologics, Inc.OTCPK: YECO | $1.02K | $0.00 | -66.67% |
| eFFECTOR Therapeutics, Inc.OTCPK: EFTR | $941.00 | $0.00 | -75.00% |
| Proteonomix, Inc.OTCPK: PROT | $791.00 | $— | — |
Figures last refreshed Oct 4, 2026.